C160rf5, a novel proline-rich gene at 16p13.3, is highly expressed in the brain

被引：5

作者：

Bhalla, K ^{[1
]}

Eyre, HJ ^{[1
]}

Whitmore, SA ^{[1
]}

Sutherland, GR ^{[1
]}

Callen, DF ^{[1
]}

机构：

[1] Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia

来源：

JOURNAL OF HUMAN GENETICS | 1999年 / 44卷 / 06期

关键词：

proline; cysteine; brain; chromosome; 16p13.3;

D O I：

10.1007/s100380050183

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

A novel gene has been characterized, designated C16orf5, with an unusually high content of proline residues (40% over 104 residues) at the N-terminus of the protein. The C-terminus of the protein is also cysteine rich with 14 cysteine residues present. Analysis using Northern and dot blots showed that the highest expression of this gene is in the brain. The gene was located on chromosome 16 at band p13.3 by FISH to metaphase chromosomes. Southern blot analysis with a human-rodent somatic cell hybrid panel showed a location between the somatic hybrid breakpoints 23HA and CY196. This gene comprises at least four exons and an open reading frame of 786bp encoding a predicted protein of 261 amino acids. Analysis of this protein using PSORTII predicted a nuclear localization.

引用

页码：383 / 387

页数：5

共 15 条

[1] CORRESPONDENCE BETWEEN A MAMMALIAN SPLICEOSOME COMPONENT AND AN ESSENTIAL YEAST SPLICING FACTOR [J].

BENNETT, M ;

REED, R .

SCIENCE, 1993, 262 (5130) :105-108

[2] INTEGRATION OF TRANSCRIPT AND GENETIC MAPS OF CHROMOSOME-16 AT NEAR-1-MB RESOLUTION - DEMONSTRATION OF A HOT-SPOT FOR RECOMBINATION AT 16P12 [J].

CALLEN, DF ;

LANE, SA ;

KOZMAN, H ;

KREMMIDIOTIS, G ;

WHITMORE, SA ;

LOWENSTEIN, M ;

DOGGETT, NA ;

KENMOCHI, N ;

PAGE, DC ;

MAGLOTT, DR ;

NIERMAN, WC ;

MURAKAWA, K ;

BERRY, R ;

SIKELA, JM ;

HOULGATTE, R ;

AUFFRAY, C ;

SUTHERLAND, GR .

GENOMICS, 1995, 29 (02) :503-511

[3] MAPPING THE SHORT ARM OF HUMAN-CHROMOSOME 16 [J].

CALLEN, DF ;

HYLAND, VJ ;

BAKER, EG ;

FRATINI, A ;

GEDEON, AK ;

MULLEY, JC ;

FERNANDEZ, KEW ;

BREUNING, MH ;

SUTHERLAND, GR .

GENOMICS, 1989, 4 (03) :348-354

[4]

CALLEN DF, 1990, ANN GENET-PARIS, V33, P219

[5] Fibroblast growth factor homologous factor 2 (FHF2):: gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient [J].

Gecz, J ;

Baker, E ;

Donnelly, A ;

Ming, JE ;

McDonald-McGinn, DM ;

Spinner, NB ;

Zackai, EH ;

Sutherland, GR ;

Mulley, JC .

HUMAN GENETICS, 1999, 104 (01) :56-63

[6] Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33 [J].

Habuchi, T ;

Luscombe, N ;

Elder, PA ;

Knowles, MA .

GENOMICS, 1998, 48 (03) :277-288

[7] The PROSITE database, its status in 1999 [J].

Hofmann, K ;

Bucher, P ;

Falquet, L ;

Bairoch, A .

NUCLEIC ACIDS RESEARCH, 1999, 27 (01) :215-219

[8]

KOZAK M, 1991, J BIOL CHEM, V266, P19867

[9] Interpreting cDNA sequences: Some insights from studies on translation [J].

Kozak, M .

MAMMALIAN GENOME, 1996, 7 (08) :563-574

[10] Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease) [J].

Marquardt, A ;

Stöhr, H ;

Passmore, LA ;

Krämer, F ;

Rivera, A ;

Weber, BHF .

HUMAN MOLECULAR GENETICS, 1998, 7 (09) :1517-1525

← 1 2 →